Halozyme Therapeutics, Inc. is a U.S. biotechnology company that develops and supports biopharmaceutical products. It lobbies Congress on issues tied to biopharmaceutical research, development, and manufacturing, and on Medicare and Medicaid coverage and reimbursement for drugs. Its filings show four reports totaling $240,000 and it hired the Forbes-Tate firm to represent these issues.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BARRETT THORNHILL
The latest disclosures for this client.
FORBES-TATE
Q4FORBES-TATE
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FORBES-TATE
ELIZABETH GREER
FORBES-TATE
JEFFREY FORBES
FORBES-TATE
mr MICHAEL ALEXANDER WILLIAMS
FORBES-TATE
FORBES-TATE
Q2FORBES-TATE
Q1